JENNIFER DAILEY: Open Payments
NPI 1356746556 · LAWRENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 4 payments from 4 companies in 2025. Trend: 2023 $366 · 2024 $393 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $97 |
| Calliditas Therapeutics US Inc. | 1 | $71 |
Products named: AMVUTTRA, REZDIFFRA, REXULTI, TARPEYO.
Industry payments across MA — which companies pay providers there.
